Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 10Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 2229Neoplasms 2031Lung Neoplasms 1094Colorectal Neoplasms 1033Prostatic Neoplasms 892Carcinoma, Non-Small-Cell Lung 751Carcinoma, Hepatocellular 672Stomach Neoplasms 606Pancreatic Neoplasms 599Head and Neck Neoplasms 433Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Urinary Bladder Neoplasms 289Leukemia, Myeloid, Acute 276Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 251Disease 241Recurrence 225Glioma 217Carcinoma, Renal Cell 207

Interventions

dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Locally Advanced Rectal Cancer (LARC) × Clear all
NCT07351708 2026-01-20

PROMISE model

Sixth Affiliated Hospital, Sun Yat-sen University

Completed
2,315 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07269249 2025-12-08

RW-NEDOS

National Cancer Institute, Naples

Recruiting
50 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡